Cytomegalovirus and pregnancy: Challenges and perspectives (PubMed, Rev Prat) - Jul 14, 2026 - "In recent years, valacyclovir has demonstrated its efficacy in reducing the risk of maternal-fetal transmission following seroconversion during pregnancy. Emerging antivirals, such as valganciclovir and letermovir, currently under evaluation, could expand treatment options. Finally, research on a vaccine are ongoing, it holds the potential to revolutionize the long-term management of this infection."
Journal • Review • Cytomegalovirus Infection • Infectious Disease
|
|
Charles Egloff; Christelle Vauloup-Fellous; Olivier Picone
|